Evidence map›Paper›PMID 30144281›Full record

ArticleAngewandte Chemie (International ed. in English)2018

Chlorophyll Breakdown in a Fern-Discovery of Phyllobilin Isomers with a Rearranged Carbon Skeleton.

Theresia Erhart, Stefan Vergeiner, Christoph Kreutz, Bernhard Kräutler, Thomas Müller

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Evolution of chlorophyll degradation is associated with plant transition to land.The Plant journal : for cell and molecular biology · 2022
    Article
  5. An evergreen mind and a heart for the colors of fall.Journal of experimental botany · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Theresia ErhartInstitute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
Stefan VergeinerInstitute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
Christoph KreutzInstitute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID 0000-0002-7018-9326
Bernhard KräutlerInstitute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID 0000-0002-2222-0587
Thomas MüllerInstitute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID 0000-0002-3400-3248

Funding

Austrian Science Fund FWF 28522Austrian Science Fund FWF P 28522
6 · The paper itself

Abstract

All structure-based information on chlorophyll (Chl) breakdown in the higher plants relies on studies with angiosperms. Herein, the first investigation of a fern is reported, revealing a novel type of Chl catabolites (phyllobilins) in leaves of this large division of the vascular plants, and providing structural insights into an astounding metabolic process of the higher plants that appears to have played a role even in early phases of plant evolution. The tetrapyrrolic Chl catabolites in the cosmopolitan bracken fern were discovered to be phyllobilin isomers with an unprecedented skeleton, proposed to be the striking result of a rearrangement of a hypothetical phyllobilin precursor.

Indexed as

CarbonChlorophyllFernsIsomerismPlant LeavesTetrapyrrolesCarbonChlorophyllTetrapyrrolesevolutionheterocyclic natural productsphotosynthesisporphyrinoidsrearrangements

Identifiers

PMID30144281
PMCPMC6220952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.